Sep 06, 2023 / 05:30PM GMT
Vikramjeet Singh Chopra - Wells Fargo Securities, LLC, Research Division - Associate Equity Analyst
Okay. Hello, everyone. My name is Vik Chopra. I'm one of the med tech analysts at Wells Fargo. I'm pleased to introduce the management team from Integra Life Sciences today, joining us as a company are Lea Knight, Integra's new CFO and EVP, and we also have Chris Ward, Senior Director of Investor Relations in the audience. Thanks so much for being here.
Questions and Answers:
Vikramjeet Singh Chopra - Wells Fargo Securities, LLC, Research Division - Associate Equity AnalystSo you recently joined Integra. What attracts you to this company. Can you just talk about -- all right, better -- and can you just talk about what changes we can expect from all the metrics that you focus on, how you report, how you guide, et cetera.
Lea Daniels Knight - Integra LifeSciences Holdings Corporation - Executive VP & CFO
Certainly. Good afternoon, everybody. I'm excited to be here, so thank you for the invitation, Vik. So why